Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Metformin vs Triple Regimen for Epidermal Melasma
NCT07779811Phase 2Not yet recruiting
- Sponsor
- Combined Military Hospital
- Start
- Aug 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 2 trial of metformin 1% gel in melasma, sponsored by Combined Military Hospital. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
metformin 1% gel
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07779811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07779811.